Jaid, Farnisa J.
HRN: 49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
AMPICILLIN 500MG (VIAL)
04/09/2022
04/06/2022
IV
400mg
Q6h
PNEUMONIA
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes